Your browser doesn't support javascript.
loading
Treatment of noninfectious uveitis.
Ferreira, Lisia Barros; Farrall, Alexandra L; Furtado, João M; Smith, Justine R.
Afiliación
  • Ferreira LB; College of Medicine & Public Health, Flinders University, Adelaide, Australia.
  • Farrall AL; College of Medicine & Public Health, Flinders University, Adelaide, Australia.
  • Furtado JM; College of Medicine & Public Health, Flinders University, Adelaide, Australia.
  • Smith JR; Division of Ophthalmology, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Arq Bras Oftalmol ; 84(6): 610-621, 2021.
Article en En | MEDLINE | ID: mdl-34431877
ABSTRACT
Uveitis is a broad term that refers to a large group of eye disorders categorized by intraocular inflammation, a leading cause of visual impairment. Historically, treatment of noninfectious uveitis has depended on corticosteroid drugs. Owing to the myriad of side effects caused by corticosteroids, immunomodulatory therapy has become the preferred treatment for chronic noninfectious intraocular inflammation. Recently, biological response modifiers have established a new era in uveitis therapy, with the range of targets continuing to expand. In this review, we aimed to convey up-to-date information on the treatment of noninfectious uveitis to the general ophthalmologist.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis Límite: Humans Idioma: En Revista: Arq Bras Oftalmol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis Límite: Humans Idioma: En Revista: Arq Bras Oftalmol Año: 2021 Tipo del documento: Article País de afiliación: Australia